Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Certain hormone treatments can improve acne and related conditions in women.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Early diagnosis and treatment of TPP can prevent complications.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Oral zinc sulphate reduces dark hair color in mice.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Rats had lasting erectile problems after stopping a certain medication.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Low prolactin in young women may increase heart and metabolism risks.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.